Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Addex Therapeutics
Addex Therapeutics
(ADXN)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Fluorodopa f-18
schizophrenia
,
alzheimer disease
,
triple negative breast neoplasms
,
non-small-cell lung carcinoma
,
non-hodgkin lymphoma
,
large b-cell lymphoma diffuse
,
recurrence
,
multiple sclerosis
,
chronic progressive multiple sclerosis
,
cognitive dysfunction
,
pick disease of the brain
,
healthy volunteers/patients
,
disease
,
dementia
,
frontotemporal dementia
,
progressive supranuclear palsy
,
neoplasms
,
cardiotoxicity
,
carotid artery diseases
,
atherosclerosis
Dipraglurant
healthy volunteers/patients
,
dystonia
,
blepharospasm
,
parkinson disease
,
dyskinesias
,
drug-induced dyskinesia
Glutamic acid
non-small-cell lung carcinoma
,
melanoma
,
uveal melanoma
RASEGLURANT
gastroesophageal reflux
,
peptic esophagitis
,
migraine disorders
D-glutamate
non-small-cell lung carcinoma
Fludeoxyglucose f-18
alzheimer disease
,
hiv infections
,
neoplasm metastasis
,
amnesia
,
pancreatic neoplasms
,
ovarian neoplasms
,
fallopian tube neoplasms
,
carcinoma
,
neoplasms
,
non-small-cell lung carcinoma
,
vascular diseases
,
atherosclerosis
,
melanoma
,
prostatic neoplasms
,
lymphoma
,
hodgkin disease
,
breast neoplasms
,
renal cell carcinoma
,
kidney neoplasms
,
glioblastoma
,
astrocytoma
,
castration-resistant prostatic neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use